Biotech financing
25WmEet 25WmEet
Biotech financing: United States United States US biotechnology financings by year Debt Follow-on and other IPOs Venture 70 60 50 US$b 40 30 20 10 0 Source: EY, Capital IQ and VentureSource. In the US, 2015 featured strong financing performance across every category. With a total of US$61.1 billion raised (up 32% from 2014’s then-record US$46.4 billion), the year featured the highest-ever venture capital, debt and follow-on financing totals. Fourth quarter financing slowed significantly, with only US$4.6 billion of the year’s total coming during the last three months of 2015. 12 Beyond borders 2016 — Biotech financing
Innovation capital in the US by year Innovation capital Capital raised by commercial leaders US$b Source: EY, Capital IQ and VentureSource. Innovation capital is the amount of capital raised by companies with revenues of less than US$500 million. US commercial leaders conducted only seven financing rounds in 2015, including four large debt deals. However, those financings accounted for US$28.8 billion in new capital, a new record. US innovation capital (US$32.3 billion) also reached a new record in 2015, narrowly topping 2014’s record high of US$30.1 billion. Beyond borders 2016 — Biotech financing 13
- Page 1 and 2: Beyond borders 2016: Biotech financ
- Page 3 and 4: Contents Financing Slowdown ahead?
- Page 5 and 6: Slowdown ahead? Since the US garner
- Page 7 and 8: Venture financing accelerates While
- Page 9 and 10: Biotechs in the US and Europe raise
- Page 11: US and European biotechnology IPOs
- Page 15 and 16: Innovation capital raised by leadin
- Page 17 and 18: US biotechnology IPOs by year Capit
- Page 19 and 20: Biotech financing: Europe Europe Eu
- Page 21 and 22: Innovation capital raised by leadin
- Page 23 and 24: Top European venture financing, 201
- Page 25 and 26: Top European biotech IPOs, 2015 Com
- Page 27 and 28: Italy Rome Antonio Irione antonio.i
- Page 29: Data exhibit index Page 8 9 10 10 1
- Page 32: EY | Assurance | Tax | Transactions
Innovation capital in the US by year<br />
Innovation capital<br />
Capital raised by commercial leaders<br />
US$b<br />
Source: EY, Capital IQ and VentureSource.<br />
Innovation capital is the amount of capital raised by companies with revenues of less than US$500 million.<br />
US commercial leaders conducted only seven <strong>financing</strong> rounds<br />
in 2015, including four large debt deals. However, those<br />
<strong>financing</strong>s accounted for US$28.8 billion in new capital, a new<br />
record. US innovation capital (US$32.3 billion) also reached a<br />
new record in 2015, narrowly topping 2014’s record high of<br />
US$30.1 billion.<br />
Beyond borders 2016 — <strong>Biotech</strong> <strong>financing</strong><br />
13
Change language